Factors Influencing Dialysis Modality for End-Stage Renal Disease in Developing Countries: A Survey of Filipino Nephrologists

2011 ◽  
Vol 32 (2) ◽  
pp. 117-123 ◽  
Author(s):  
Dinna N. Cruz ◽  
Laura Troidle ◽  
Romina Danguilan ◽  
Benita Padilla ◽  
Leilani Frando ◽  
...  
2019 ◽  
Vol 4 (7) ◽  
pp. S14-S15
Author(s):  
Z.E.B. KHOO ◽  
S.C. Yeo ◽  
P. Shen ◽  
L.K.E. Pang ◽  
A. Liew

PEDIATRICS ◽  
1997 ◽  
Vol 99 (4) ◽  
pp. e6-e6 ◽  
Author(s):  
S. L. Furth ◽  
N. R. Powe ◽  
W. Hwang ◽  
A. M. Neu ◽  
B. A. Fivush

2019 ◽  
Vol 39 (6) ◽  
pp. 562-567 ◽  
Author(s):  
Tripti Singh ◽  
Brad C. Astor ◽  
Sana Waheed

Introduction Low serum albumin is associated with high mortality in patients with end-stage renal disease (ESRD) on chronic dialysis. Clinicians are reluctant to offer peritoneal dialysis (PD) as an option for dialysis for patients with low serum albumin due to concerns of loss of albumin with PD, but evidence supporting differences in outcomes is limited. We evaluated mortality based on dialysis modality in patients with very low serum albumin (< 2.5 g/dL). Methods We analyzed United States Renal Data System (USRDS) data from 2010 to 2015 to assess mortality by modality adjusted for age, sex, race, employment, number of comorbidities, and year of dialysis initiation. Results Low serum albumin (< 2.5 g/dL) was present in 78,625 (19.9%) of 395,656 patients with ESRD on chronic dialysis. Patients with low serum albumin were less likely to use PD as their first modality than those with higher albumin (3.1% vs 10.9%; p < 0.001). Use of PD was associated with lower mortality compared with hemodialysis (HD) (hazard ratio [HR] = 0.88, 95% confidence interval [CI] 0.81 – 0.95, p < 0.05) in patients with low serum albumin. This difference was more pronounced in patients who had glomerulonephritis (HR = 0.72) or hypertension (HR = 0.81) than in those with end-stage renal disease (ESRD) due to diabetes mellitus or other causes. Conclusion Peritoneal dialysis is less likely to be the first dialysis modality in patients with low serum albumin requiring dialysis. However, PD is associated with lower mortality than HD in patients with low serum albumin on dialysis. We recommend advocating the use of PD in patients with low serum albumin.


2014 ◽  
Vol 176 (3) ◽  
pp. 1097-1099 ◽  
Author(s):  
Vinay Bahadur Panday ◽  
Zi-Ping Tong ◽  
Perryn L. Ng ◽  
Evan J. Lee ◽  
Titus Lau ◽  
...  

Renal Failure ◽  
2010 ◽  
Vol 32 (8) ◽  
pp. 947-953 ◽  
Author(s):  
Jae Hyun Chang ◽  
Se-Jung Yoon ◽  
Seung Hyeok Han ◽  
Sug Kyun Shin ◽  
Dong Woon Jeon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document